1. Home
  2. GOCO vs ENTA Comparison

GOCO vs ENTA Comparison

Compare GOCO & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOCO
  • ENTA
  • Stock Information
  • Founded
  • GOCO 2001
  • ENTA 1995
  • Country
  • GOCO United States
  • ENTA United States
  • Employees
  • GOCO 2261
  • ENTA N/A
  • Industry
  • GOCO Specialty Insurers
  • ENTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • GOCO Finance
  • ENTA Health Care
  • Exchange
  • GOCO Nasdaq
  • ENTA Nasdaq
  • Market Cap
  • GOCO 66.6M
  • ENTA 131.7M
  • IPO Year
  • GOCO 2020
  • ENTA 2013
  • Fundamental
  • Price
  • GOCO $5.70
  • ENTA $7.50
  • Analyst Decision
  • GOCO Hold
  • ENTA Buy
  • Analyst Count
  • GOCO 1
  • ENTA 4
  • Target Price
  • GOCO $18.00
  • ENTA $18.00
  • AVG Volume (30 Days)
  • GOCO 55.0K
  • ENTA 173.7K
  • Earning Date
  • GOCO 08-07-2025
  • ENTA 08-04-2025
  • Dividend Yield
  • GOCO N/A
  • ENTA N/A
  • EPS Growth
  • GOCO N/A
  • ENTA N/A
  • EPS
  • GOCO N/A
  • ENTA N/A
  • Revenue
  • GOCO $834,266,000.00
  • ENTA $64,462,999.00
  • Revenue This Year
  • GOCO $8.51
  • ENTA N/A
  • Revenue Next Year
  • GOCO $7.19
  • ENTA $0.48
  • P/E Ratio
  • GOCO N/A
  • ENTA N/A
  • Revenue Growth
  • GOCO 13.18
  • ENTA N/A
  • 52 Week Low
  • GOCO $5.40
  • ENTA $4.09
  • 52 Week High
  • GOCO $21.00
  • ENTA $17.24
  • Technical
  • Relative Strength Index (RSI)
  • GOCO 33.25
  • ENTA 65.91
  • Support Level
  • GOCO $5.66
  • ENTA $7.01
  • Resistance Level
  • GOCO $6.26
  • ENTA $8.47
  • Average True Range (ATR)
  • GOCO 0.42
  • ENTA 0.48
  • MACD
  • GOCO 0.16
  • ENTA 0.10
  • Stochastic Oscillator
  • GOCO 23.09
  • ENTA 64.98

About GOCO GoHealth Inc.

GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions so consumers can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. Its proprietary technology platform leverages modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

Share on Social Networks: